EVOK · Evoke Pharma, Inc.

Evoke Pharma, Inc. Operates As A Specialized Pharmaceutical Entity, Primarily Focused On Inventing And Bringing To Market Therapeutic Agents For Various Digestive System Illnesses. The Company'S Lead Development Candidate Is Gimoti, A Metoclopramide Nasal Spray, Which Has Progressed Through And Completed Its Phase 3 Clinical Trials. This Medicine Is Being Developed To Mitigate Symptoms Associated With Both Acute And Recurring Diabetic Gastroparesis, Specifically In Female Patients. Evoke Pharma Distributes Its Offerings To A Broad Base Of Healthcare Professionals, Encompassing Digestive Disease Specialists, Internists, General Practitioners, And Certain Other Medical Providers. Established In 2007, The Company'S Corporate Offices Are Situated In Solana Beach, California.